These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 34257426)

  • 1. COVID-19 long haulers.
    Schmidt C
    Nat Biotechnol; 2021 Aug; 39(8):908-913. PubMed ID: 34257426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamers Against COVID-19: An Untested Opportunity.
    Haberland A; Müller J
    Mini Rev Med Chem; 2022; 22(13):1708-1715. PubMed ID: 35023454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-COVID treatments: why the world is still waiting.
    Ledford H
    Nature; 2022 Aug; 608(7922):258-260. PubMed ID: 35945375
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic COVID syndrome: Need for an appropriate medical terminology for long-COVID and COVID long-haulers.
    Baig AM
    J Med Virol; 2021 May; 93(5):2555-2556. PubMed ID: 33095459
    [No Abstract]   [Full Text] [Related]  

  • 5. "LONG COVID"-A hypothesis for understanding the biological basis and pharmacological treatment strategy.
    Jarrott B; Head R; Pringle KG; Lumbers ER; Martin JH
    Pharmacol Res Perspect; 2022 Feb; 10(1):e00911. PubMed ID: 35029046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies for the treatment of COVID-19 in a patient with high-risk acute leukaemia.
    Saultier P; Ninove L; Szepetowski S; Veneziano M; Visentin S; Barlogis V; Saba Villarroel PM; Amroun A; Loosveld M; de Lamballerie X; Chambost H
    Br J Haematol; 2022 Jan; 196(1):e1-e3. PubMed ID: 34337739
    [No Abstract]   [Full Text] [Related]  

  • 7. Re-purposed antiviral drugs without a purpose in COVID-19: a valuable lesson for clinicians.
    Liuzzo G; Patrono C
    Eur Heart J; 2021 Mar; 42(9):882-883. PubMed ID: 33569601
    [No Abstract]   [Full Text] [Related]  

  • 8. The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus-2: Part 5.
    Frishman WH
    Cardiol Rev; 2021 May-Jun 01; 29(3):109. PubMed ID: 33758124
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug repositioning is an alternative for the treatment of coronavirus COVID-19.
    Serafin MB; Bottega A; Foletto VS; da Rosa TF; Hörner A; Hörner R
    Int J Antimicrob Agents; 2020 Jun; 55(6):105969. PubMed ID: 32278811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chasing COVID-19 chemotherapeutics without putting the cart before the horse.
    Rannard SP; McDonald TO; Owen A
    Br J Clin Pharmacol; 2023 Jan; 89(1):421-423. PubMed ID: 33217038
    [No Abstract]   [Full Text] [Related]  

  • 11. Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment.
    Martinez MA
    Front Immunol; 2021; 12():635371. PubMed ID: 33777024
    [No Abstract]   [Full Text] [Related]  

  • 12. NPC1 as a Modulator of Disease Severity and Viral Entry of SARSCoV- 2.
    Vial C; Calderón JF; Klein AD
    Curr Mol Med; 2021; 21(1):2-4. PubMed ID: 32660402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does anti-viral treatment in acute COVID infection decrease the risk of developing the Long-COVID Syndrome?
    QJM; 2022 Jan; 114(12):841-842. PubMed ID: 35020945
    [No Abstract]   [Full Text] [Related]  

  • 14. The immunology and immunopathology of COVID-19.
    Merad M; Blish CA; Sallusto F; Iwasaki A
    Science; 2022 Mar; 375(6585):1122-1127. PubMed ID: 35271343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Approaches of Repositioning and Traditional Drugs for the Treatment of COVID-19 Pandemic Outbreak.
    Tandon N; Luxami V; Tandon R; Paul K
    Mini Rev Med Chem; 2021; 21(8):952-968. PubMed ID: 33234101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposed Drugs Failed to Prevent Severe COVID-19.
    Slomski A
    JAMA; 2022 Sep; 328(12):1171. PubMed ID: 36166031
    [No Abstract]   [Full Text] [Related]  

  • 17. Post-acute sequelae of SARS-CoV-2 infection: Caring for the 'long-haulers'.
    Vehar S; Boushra M; Ntiamoah P; Biehl M
    Cleve Clin J Med; 2021 May; 88(5):267-272. PubMed ID: 33941600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Current Status of Drug Repositioning and Vaccine Developments for the COVID-19 Pandemic.
    Won JH; Lee H
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating the host immune response to fight against COVID-19: Where are we in 2021?
    Hertanto DM; Sutanto H; Wiratama BS; Wungu CDK
    Virulence; 2021 Dec; 12(1):1732-1736. PubMed ID: 34224330
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic targets and potential agents for the treatment of COVID-19.
    Wu Y; Li Z; Zhao YS; Huang YY; Jiang MY; Luo HB
    Med Res Rev; 2021 May; 41(3):1775-1797. PubMed ID: 33393116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.